• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同着床失败次数患者宫腔内注射人绒毛膜促性腺激素的效果。

Effects of intrauterine perfusion of human chorionic gonadotropin in women with different implantation failure numbers.

机构信息

Guangxi Medical University, Nanning, China.

Reproductive Medicine Center, Liuzhou Maternal and Child Healthcare Hospital, Liuzhou, China.

出版信息

Am J Reprod Immunol. 2018 Feb;79(2). doi: 10.1111/aji.12809. Epub 2017 Dec 30.

DOI:10.1111/aji.12809
PMID:29288552
Abstract

PROBLEM

The aim of this research was to investigate the effects of the intrauterine perfusion of hCG before a frozen-thawed embryo transfer (FET) in women with different implantation failure numbers.

METHOD OF STUDY

This was a retrospective analysis of patients undergoing FET who received an intrauterine injection hCG 1000 IU before embryo transfer. The groups included women with their first implantation failure (A group, n = 26), second implantation failure (B group, n = 122), and three or more failures (C group, n = 77). Corresponding control groups (no infusion) were also included. The pregnancy rates were compared among these groups.

RESULTS

After intrauterine injection hCG, the biochemical pregnancy rates were 92.30%, 63.11%, 49.02%, and the clinical pregnancy rates were 76.92%, 54.91%, 48.05%, in the A, B, and C groups, respectively. The biochemical and clinical pregnancy rates were significantly higher in the A group than in the other groups (P < .05). The clinical pregnancy rates of the A and C groups were significantly higher than in the corresponding (no infusion) control groups (76.92% vs 56.81% and 48.05% vs 33.33%, P < .05).

CONCLUSION

Pregnancy rates decreased with the number of transplant failures. The intrauterine administration of hCG before FET significantly improved the pregnancy rates, especially after one and three or more implantation failures.

摘要

问题

本研究旨在探讨在冻融胚胎移植(FET)前宫腔内注射 hCG 对不同着床失败次数的女性的影响。

方法

这是一项对接受 FET 且胚胎移植前宫腔内注射 1000IU hCG 的患者进行的回顾性分析。研究组包括首次着床失败的患者(A 组,n=26)、第二次着床失败的患者(B 组,n=122)和三次或更多次失败的患者(C 组,n=77)。还包括相应的对照组(未输注)。比较这些组之间的妊娠率。

结果

宫腔内注射 hCG 后,A、B 和 C 组的生化妊娠率分别为 92.30%、63.11%和 49.02%,临床妊娠率分别为 76.92%、54.91%和 48.05%。A 组的生化和临床妊娠率明显高于其他组(P<0.05)。A 组和 C 组的临床妊娠率明显高于相应的对照组(76.92%比 56.81%和 48.05%比 33.33%,P<0.05)。

结论

移植失败次数越多,妊娠率越低。FET 前宫腔内注射 hCG 可显著提高妊娠率,尤其是在一次或三次以上着床失败后。

相似文献

1
Effects of intrauterine perfusion of human chorionic gonadotropin in women with different implantation failure numbers.不同着床失败次数患者宫腔内注射人绒毛膜促性腺激素的效果。
Am J Reprod Immunol. 2018 Feb;79(2). doi: 10.1111/aji.12809. Epub 2017 Dec 30.
2
A study of intrauterine infusion of human chorionic gonadotropin (hCG) before frozen-thawed embryo transfer after two or more implantation failures.一项关于在两次或更多次植入失败后冻融胚胎移植前宫腔内输注人绒毛膜促性腺激素(hCG)的研究。
Gynecol Endocrinol. 2017 Jan;33(1):67-69. doi: 10.1080/09513590.2016.1207164. Epub 2016 Jul 22.
3
Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.取卵后立即宫腔内注射人绒毛膜促性腺激素与卵胞浆内单精子注射结局:一项随机对照试验
Hum Reprod. 2016 Nov;31(11):2520-2526. doi: 10.1093/humrep/dew236. Epub 2016 Sep 28.
4
Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study.胚胎移植前宫腔内注射人绒毛膜促性腺激素显著提高体外受精/卵胞浆内单精子注射的种植率和妊娠率:一项前瞻性随机研究。
Fertil Steril. 2011 Dec;96(6):1370-1374.e1. doi: 10.1016/j.fertnstert.2011.09.044. Epub 2011 Nov 1.
5
Clinical outcome of intrauterine administration of peripheral mononuclear cells or human chorionic gonadotropin in unexplained implantation failure.不明原因植入失败中宫内注射外周血单个核细胞或人绒毛膜促性腺激素的临床结局
Am J Reprod Immunol. 2022 May;87(5):e13529. doi: 10.1111/aji.13529. Epub 2022 Mar 6.
6
Increased implantation rate after intrauterine infusion of a small volume of human chorionic gonadotropin at the time of embryo transfer: a randomized, double-blind controlled study.胚胎移植时宫腔内注射小剂量人绒毛膜促性腺激素增加胚胎种植率:一项随机、双盲对照研究。
Arch Gynecol Obstet. 2019 Jan;299(1):267-275. doi: 10.1007/s00404-018-4962-7. Epub 2018 Nov 17.
7
Effect of intrauterine perfusion of human chorionic gonadotropin before embryo transfer after two or more implantation failures: A systematic review and meta-analysis.两次或两次以上着床失败后胚胎移植前行宫腔内人绒毛膜促性腺激素灌注的效果:一项系统评价和荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2019 Dec;243:133-138. doi: 10.1016/j.ejogrb.2019.10.039. Epub 2019 Oct 28.
8
Intrauterine administration of human chorionic gonadotropin improves the live birth rates of patients with repeated implantation failure in frozen-thawed blastocyst transfer cycles by increasing the percentage of peripheral regulatory T cells.宫腔内注射人绒毛膜促性腺激素通过增加外周调节性 T 细胞的比例提高反复种植失败患者冻融胚胎移植周期的活产率。
Arch Gynecol Obstet. 2019 Apr;299(4):1165-1172. doi: 10.1007/s00404-019-05047-6. Epub 2019 Jan 19.
9
Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure.宫腔内注射人绒毛膜促性腺激素激活的自体人外周血单个核细胞(PBMC)可提高反复种植失败患者冻融胚胎移植周期的活产率。
J Reprod Immunol. 2017 Feb;119:15-22. doi: 10.1016/j.jri.2016.11.006. Epub 2016 Nov 27.
10
The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.低剂量人绒毛膜促性腺激素联合人绝经期促性腺激素方案对接受体外受精卵巢刺激的低促性腺激素性性腺功能减退症妇女的影响。
Clin Endocrinol (Oxf). 2018 Jan;88(1):77-87. doi: 10.1111/cen.13481. Epub 2017 Oct 16.

引用本文的文献

1
Progestin-primed ovarian stimulation (PPOS) in preimplantation genetic testing for aneuploidy: a retrospective study and meta-analysis.用于非整倍体植入前基因检测的孕激素预处理卵巢刺激(PPOS):一项回顾性研究和荟萃分析
Arch Gynecol Obstet. 2025 Apr;311(4):1181-1193. doi: 10.1007/s00404-024-07918-z. Epub 2025 Feb 13.
2
Meta-analysis of intrauterine hCG perfusion efficacy in recurrent implantation failure as defined by ESHRE guidelines.ESHRE 指南定义的复发性着床失败患者宫腔内 hCG 灌注疗效的荟萃分析。
BMC Pregnancy Childbirth. 2024 Jul 9;24(1):468. doi: 10.1186/s12884-024-06662-1.
3
ESHRE good practice recommendations on recurrent implantation failure.
欧洲人类生殖与胚胎学会关于反复种植失败的良好实践建议。
Hum Reprod Open. 2023 Jun 15;2023(3):hoad023. doi: 10.1093/hropen/hoad023. eCollection 2023.
4
Efficacy of Platelet-Rich Plasma in Women with a History of Embryo Transfer Failure: A Systematic Review and Meta-Analysis with Trial Sequential Analysis.富血小板血浆对有胚胎移植失败史女性的疗效:一项采用序贯试验分析的系统评价和荟萃分析
Bioengineering (Basel). 2023 Feb 27;10(3):303. doi: 10.3390/bioengineering10030303.
5
Effects of human chorionic gonadotropin intrauterine injection on oocyte retrieval day on assisted reproductive techniques outcomes: An RCT.人绒毛膜促性腺激素宫腔内注射对辅助生殖技术结局中取卵日的影响:一项随机对照试验。
Int J Reprod Biomed. 2021 Oct 10;19(9):773-780. doi: 10.18502/ijrm.v19i9.9709. eCollection 2021 Sep.
6
Human Chorionic Gonadotropin-Mediated Immune Responses That Facilitate Embryo Implantation and Placentation.人绒毛膜促性腺激素介导的免疫反应促进胚胎着床和胎盘形成。
Front Immunol. 2019 Dec 10;10:2896. doi: 10.3389/fimmu.2019.02896. eCollection 2019.
7
Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.对接受辅助生殖的不育妇女进行人绒毛膜促性腺激素(hCG)的宫内给药。
Cochrane Database Syst Rev. 2018 Oct 20;10(10):CD011537. doi: 10.1002/14651858.CD011537.pub3.